Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

alcon couvreur, belgium - hypromellose 2208 (750 mpa.s),dextran 70,carboxymethylcellulose sodium - ophthalmic solution - 3,1,3 mg,

New Zealand - English - Medsafe (Medicines Safety Authority)

alcon laboratories (australia) pty ltd - chondroitin, hyaluronic acid - solution for injection - viscoelastic solution is indicated for use as an ophthalmic surgical aid in the anterior segment during cataract extraction. ophthalmic viscoelastic solutions serve to maintain a deep anterior chamber during anterior segment surgery, thereby reducing trauma to the corneal endothelium and surrounding ocular tissues. they help to push back the vitreous face and prevent formation of a flat chamber postoperatively

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

alcon laboratories (malaysia) sdn. bhd. - atropine sulphate -

Tanzania - English - Tanzania Medicinces & Medical Devices Authority

alcon-couvreur nv, south africa - moxifloxacin - solution - 5mg/ml

Tanzania - English - Tanzania Medicinces & Medical Devices Authority

alcon-couvreur nv, south africa - dextran - solution

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

alcon couvreur, belgium - tropicamide - eye drops, solution - 1 %

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

alcon couvreur, belgium - sodium hyaluronate - injection - 10 mg/ml

Israel - English - Ministry of Health

novartis israel ltd - ciprofloxacin as hydrochloride - solution - ciprofloxacin as hydrochloride 3 mg/ml - ciprofloxacin - ciprofloxacin - corneal ulcers and conjunctivitis caused by susceptible gram positive and gram negative microorganisms for adults and pediatric patients above the age of 1 year. for localized or diffuse otitis externa accompanied by a strong inflammatory reaction and of which the strains are susceptible to ciprofloxacin, and for the acute flare-up of a chronic otitis media. in this case, a mucopurulent secretion comes through the perforated eardrum. pseudomonas aeruginosa is one of the organisms most likely to be found in this case. also in other infections of the ear in which pseudomonas aeruginosa and/or other susceptible strains may be demonstrated or suspected (for example with suppurating tympanic tubes), ciloxan can be used under the strict supervision of an ear specialist. it must be understood that this is not a routine treatment and that improper use must be avoided.

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

novartis corporation (malaysia) sdn. bhd. - travoprost -

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

novartis corporation (malaysia) sdn. bhd. - tobramycin -